ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    A Transcriptomic Signature in PBMC from Kidney Transplant Recipients at Baseline Predicts Early Acute Rejection

    W. Zhang,1 Z. Yi,1 P. Cravedi,1 L. Li,1 K. Keung,2 C. Wei,1 M. Menon,1 J. Dudley,1 P. O'Connell,2 B. Murphy.1

    1Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; 2Medicine, The University of Sydney, Sydney, Australia.

    Background: Our multi-center study (Genomics of Chronic Allograft Rejection, GoCAR) revealed that early acute rejection (EAR, developed before 6 months post-transplant) is associated with later…
  • 2018 American Transplant Congress

    Proton-Pump Inhibitor Utilization is Associated with Higher Rates of Clostridium difficile Infection and Hypomagnesemia after Kidney Transplant

    G. Kipp,2 K. Dancsecs,1 A. Lapping.1

    1School of Pharmacy, Duquesne University, Pittsburgh, PA; 2Abdominal Transplant, Allegheny General Hospital, Pittsburgh, PA.

    The purpose of this project was to identify how many kidney transplant patients were taking a proton pump inhibitor (PPI) after kidney transplant at our…
  • 2018 American Transplant Congress

    Intragraft Gene Expression Differentiates Polyomavirus Nephropathy from T-Cell Mediated Rejection

    B. Adam,1 S. Wagner,1 J. Bräsen,2 V. Bröcker,2 V. D'Agati,3 C. Drachenberg,4 E. Farkash,5 A. Farris,6 L. Geldenhuys,7 A. Magil,8 V. Nickeleit,9 P. Randhawa,10 H. Regele,11 M. Mengel.1

    1University of Alberta, Edmonton, Canada; 2Hannover Medical School, Hannover, Germany; 3Columbia University, New York; 4University of Maryland, College Park; 5University of Michigan, Ann Arbor; 6Emory University, Atlanta; 7Dalhousie University, Halifax, Canada; 8University of British Columbia, Vancouver, Canada; 9University of North Carolina, Chapel Hill; 10University of Pittsburgh, Pittsburgh; 11Medical University of Vienna, Vienna, Austria.

    Background: Improved immunosuppression protocols have reduced the incidence of T-cell mediated rejection (TCMR) but still carry a significant risk of BK polyomavirus nephropathy (BKVN). Despite…
  • 2018 American Transplant Congress

    Expression of the Senescence Marker P16/INK4A in Kidney Implantation Biopsies is Uniquely Associated with Poor Late Graft Function

    K. Famulski, P. Halloran.

    University of Alberta, Edmonton, Canada.

    With the aging donor population, accurate assessment of tissue quality of deceased donor kidneys is required to determine the intermediate and long term graft performance,…
  • 2018 American Transplant Congress

    Medication Reconciliation in Abdominal Transplantation

    S. Todd,1 J. Perryman,2 R. Subramanian,2 A. Patel,2 M. Hawthorne,2 R. Buenvenida,2 K. Lee,2 W. Allison,2 D. Lo,2 P. Reshamwala.2

    1Department of Pharmacy, Emory University Hospital, Atlanta, GA; 2Emory Transplant Center, Emory University Hospital, Atlanta, GA.

    Medication adherence post transplantation is vital. Upon discharge, abdominal transplant patients receive a medication list from the electronic medical record (EMR) and obtain a medication…
  • 2018 American Transplant Congress

    Urine AngiotensinII Signature Proteins as Biomarkers of Fibrosis in Kidney Transplant Recipients

    Z. Mohammed-Ali,1 S. Reid,1,3 T. Tokar,1 A. Tavares,2 P. Yip,1 H. Cardinal,2 Y. Li,1 S. Kim,1,3 I. Jurisica,1,3 R. John,1 A. Konvalinka.1,3

    1University Health Network, Toronto, ON, Canada; 2Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada; 3University of Toronto, Toronto, ON, Canada.

    AngiotensinII (AngII), the main effector of the renin-angiotensin system (RAS), causes kidney interstitial fibrosis/tubular atrophy (IFTA). However, there are presently no markers of AngII renal…
  • 2018 American Transplant Congress

    Molecular Classifiers Can Outperform the Flawed Histologic “Gold Standard” on Which They Are Trained

    J. Reeve, P. Halloran.

    University of Alberta, Edmonton, Canada.

    The histologic diagnosis of rejection in organ transplants is known to be an imperfect gold standard. Therefore, it might be assumed that molecular classifiers built…
  • 2018 American Transplant Congress

    Subclass Distribution of DSA Analyzed by Mass Spectrometry Predicts the Risk of Humoral Rejection

    V. Pernin,1,2 N. Bec,3 C. Larroque,3 C. Duperray,2 G. Mourad,1 M. Lequintrec.1,2

    1Department of Nephrology, Dialysis and Kidney Transplantation, CHU Lapeyronie, Montpellier, France; 2INSERM U1183 Institute for Regenerative Medicine & Biotherapy (IRMB), Montpellier, France; 3Institut de Recherche en Cancérologie de Montpellier (IRCM)- CRLC Val d'Aurelle - Paul Lamarque - INSERM U896, Montpellier, France.

    Background :DSA occurrence after kidney transplant is a main risk factor for humoral rejection and graft loss, however graft outcomes after DSA detection is very…
  • 2018 American Transplant Congress

    Noninvasive Detection of Infection and Rejection in Renal Transplant Patients

    Y. Zhou,1 Y. Cheng,1 T. Chiang,2 G. Yang,2 X. Li,2 F. Zeng,2 X. Wang,1 J. Ge,2 X. Hu,2 H. Shi,1 T. Wang,2 L. Liu.3

    1Laboratory of Transplant Genomics, Jiangsu University Institute of Life Science, ZhenJiang, JingSu, China; 2Reasearch and Development Dpartment, SuZhou RRGene.Co.Ltd., SuZhou, JiangSu, China; 3Department of Urological Organ Transplantation, The Second XiangYa Hospital of Center South University, ChangSha, Hunan, China.

    About 35% of patients would suffer actue rejection or infectionin in two years after reanl trandplantation.Cell-free DNA (cfDNA) is a new biomarker to evluate health…
  • 2018 American Transplant Congress

    HLA Desensitization Using Rituximab/ Immunoadsorption before Kidney Transplantation

    P. Malvezzi, T. Jouve, D. Masson, J. Maurizi, B. Bardy, P-.L. Carron, B. Janbon, N. Terrier, L. Rostaing.

    Nephrology, Hemodialyis, Apheresis and Transplantation, CHU Grenoble-Alpes, Grenoble, France.

    Introduction: Many kidney-transplant (KT) candidates are sensitized against HLA-antigens, making it difficult to find a suitable HLA-compatible donor. Pretransplant HLA-desensitization strategies have shown improved patient…
  • « Previous Page
  • 1
  • …
  • 264
  • 265
  • 266
  • 267
  • 268
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences